Platelet Autophagy as a Druggable Intracellular Pathway: Therapeutic Opportunities in Thromboinflammatory Diseases

Platelet hyperreactivity is a central driver of thromboinflammatory diseases, including ischemic stroke, cardiovascular disorders, and autoimmune conditions. Current antiplatelet therapies primarily target surface receptors or coagulation pathways and are frequently limited by drug resistance, bleed...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Ting-Lin Yen, Jing-Shiun Jan, Ruei-Dun Teng, Pi-Chan Ko, Rajeev Taliyan, Chih-Hao Yang, Jui-Ming Sun, Joen-Rong Sheu
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	MDPI AG 2026-02-01
Σειρά:	Pharmaceutics
Θέματα:	platelet autophagy drug targeting intracellular therapeutics thromboinflammation pharmacological modulation precision medicine
Διαθέσιμο Online:	https://www.mdpi.com/1999-4923/18/3/293
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!